Captopril in the treatment of hypertension in type i and type Ii diabetic patients
Gambaro, G.; Morbiato, F.; Cicerello, E.; Del Turco, M.; Sartori, L.; D'Angelo, A.; Crepaldi, G.
Journal of Hypertension. Suppl Official Journal of the International Society of Hypertension 3(2): S149-S151
1985
ISSN/ISBN: 0952-1178 PMID: 3910773 Document Number: 254815
Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.
Document emailed within 1 workday
Related Documents
Sato, N.; Kase, H.; Kato, T.; Kasai, K. 2003: Effect of angiotensin Ii type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1245-1249Niskanen, L.K.; Uusitupa, M.I.; Pyörälä, K. 1991: The relationship of hyperinsulinaemia to the development of hypertension in type 2 diabetic patients and in non-diabetic subjects Journal of Human Hypertension 5(3): 155-159
Knight, K.M.; Thornburg, L.L.; Pressman, E.K. 2012: Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiabetic controls Journal of Reproductive Medicine 57(9-10): 397-404
Zazgornik, J.; Biesenbach, G.; Janko, O.; Grafinger, P.; Kaiser, W.; Stuby, U.; Hubmann, R. 1996: Serum uric acid level in type 1 and type 2 diabetic patients Wiener Medizinische Wochenschrift 146(5): 102-104
Zebrowska-Lupina, I.; Kolber-Postepska, B.; Markiewicz, M.; Horubała-Bielak, G. 1994: Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension Wiadomosci Lekarskie 47(7-8): 241-247
Inoue, M.; Oishi, C.; Shimajiri, Y.; Furuta, M.; Ueyama, M.; Sanke, T. 2008: Clinical usefulness of measurement of urine type IV collagen for detection of early phase of nephropathy in type 2 diabetic patients Rinsho Byori. Japanese Journal of Clinical Pathology 56(7): 564-569
Moiseev, V.S.; Konurina, I.I.; Krasnobaeva, G.M.; Ivleva, A.I. 1995: Significance of assessment of natriuresis and diuresis in the course of isradipine treatment of hypertension in patients with hypertension and type Ii diabetes Klinicheskaia Laboratornaia Diagnostika 1: 18-20
Drivsholm, T.B.; Snorgaard, O. 2012: Organization of treatment and control of type 2 diabetic patients Ugeskrift for Laeger 174(37): 2159-2162
Gin, H.; Perlemoine, C.; Raffaitin, C.; Rigalleau, V. 2006: Treatment of type Ii diabetic patients with chronic renal failure Nephrologie and Therapeutique 2(Suppl 1): S59-S62
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189
Alebiosu, C.Olutayo.; Odusan, O.; Jaiyesimi, A. 2003: Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients Journal of the National Medical Association 95(11): 1042-1047
Meyer-Schwickerath, E.; Scheider, A.; Thurau, S.R.; Ulbig, M.; Landgraf, R.; Kampik, A.; Land, W. 1993: Does combined pancreas-kidney transplantation modify diabetic retinopathy in type-1 diabetic patients? Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 90(3): 283-288
Zhou, Y.; Guo, L.-x.; Yu, D.-n.; Zhou, L.; Wang, Y.; Mou, Z.-q.; Wang, X.-x.; Zhang, L.-n.; Li, M. 2012: Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 610-613
Botta, R.M.; Migliore, M.G.; Sorrentino, M.; Pagano, G. 1984: Triglyceride and cholesterol levels during pregnancy in type I, type II and gestational diabetic women Bollettino della Societa Italiana di Biologia Sperimentale 60(11): 2055-2059
Hajra, B.; Orakzai, B.A.; Faryal, U.; Hassan, M.; Rasheed, S.; Wazir, S. 2016: Insulin Sensitivity to Trace Metals (Chromium, Manganese) in Type 2 Diabetic Patients and Non Diabetic Individuals Journal of Ayub Medical College Abbottabad: Jamc 28(3): 534-536
Dąbrowski, M.; Mielnik-Niedzielska, G.ży.; Nowakowski, A. 2013: Impact of different modifiable factors on hearing function in type 1 and type 2 diabetic subjects. a preliminary study Annals of Agricultural and Environmental Medicine: Aaem 20(4): 773-778
Boero, R.; Prodi, E.; Borsa, S.; Berti, V.; Fiorio, E.; Ferraro, L.; Massara, C.; Quarello, F. 2002: Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(4): 413-418
Rajzer, M.; Kawecka-Jaszcz, K.; Wojciechowska, W. 2003: Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research Przeglad Lekarski 60(2): 111-115
Tomić, N.G.; Marusić, S.ćk.; Bozikov, V.; Kusec, R.; Bacić-Vrca, V.; Tadić, M. 2013: The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients Collegium Antropologicum 37(3): 789-793
Tangjai, P.; Chingchana, P.; Taweerutchana, R. 2015: Glycated Haemoglobin and Diabetic Retinopathy in Type 2 Diabetic Patients in HRH Princess Maha Chakri Sirindhorn Medical Center Journal of the Medical Association of Thailand 98(Suppl 10): S135-S142